Xingliang Guo

h-index

Research activity per year

Fingerprint

Dive into the research topics where Xingliang Guo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ ZAP70 Signaling Axis
Acharya, S., Basar, R., Daher, M., Rafei, H., Li, P., Uprety, N., Ensley, E., Shanley, M., Kumar, B., Banerjee, P. P., Garcia, L. M., Lin, P., Mohanty, V., Kim, K. H., Jiang, X., Pan, Y., Li, Y., Liu, B., Nunez Cortes, A. K. & Zhang, C. & 27 others, Fathi, M., Rezvan, A., Montalvo, M. J., Cha, S. L., Reyes-Silva, F., Shrestha, R., Guo, X., Kundu, K., Biederstädt, A., Muniz-Feliciano, L., Deyter, G. M., Kaplan, M., Jiang, X. R., Liu, E., Jain, A., Roszik, J., Fowlkes, N. W., Solis Soto, L. M., Raso, M. G., Khoury, J. D., Lin, P., Vega, F., Varadarajan, N., Chen, K., Marin, D., Shpall, E. J. & Rezvani, K., Oct 1 2024, In: Cancer discovery. 14, 10, p. 1879-1900 22 p.
Research output: Contribution to journal › Article › peer-review

Open Access
37 Link opens in a new tab Scopus citations
Correction to: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape (Nature Medicine, (2022), 28, 10, (2133-2144), 10.1038/s41591-022-02003-x)
Li, Y., Basar, R., Wang, G., Liu, E., Moyes, J. S., Li, L., Kerbauy, L. N., Uprety, N., Fathi, M., Rezvan, A., Banerjee, P. P., Muniz-Feliciano, L., Laskowski, T. J., Ensley, E., Daher, M., Shanley, M., Mendt, M., Acharya, S., Liu, B. & Biederstädt, A. & 12 others, Rafei, H., Guo, X., Melo Garcia, L., Lin, P., Ang, S., Marin, D., Chen, K., Bover, L., Champlin, R. E., Varadarajan, N., Shpall, E. J. & Rezvani, K., Mar 2024, In: Nature medicine. 30, 3, p. 906 1 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
1 Link opens in a new tab Scopus citations
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape
Li, Y., Basar, R., Wang, G., Liu, E., Moyes, J. S., Li, L., Kerbauy, L. N., Uprety, N., Fathi, M., Rezvan, A., Banerjee, P. P., Muniz-Feliciano, L., Laskowski, T. J., Ensley, E., Daher, M., Shanley, M., Mendt, M., Acharya, S., Liu, B. & Biederstädt, A. & 12 others, Rafei, H., Guo, X., Melo Garcia, L., Lin, P., Ang, S., Marin, D., Chen, K., Bover, L., Champlin, R. E., Varadarajan, N., Shpall, E. J. & Rezvani, K., Oct 2022, In: Nature medicine. 28, 10, p. 2133-2144 12 p.
Research output: Contribution to journal › Article › peer-review

Open Access
149 Link opens in a new tab Scopus citations

Xingliang Guo

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ ZAP70 Signaling Axis

Correction to: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape (Nature Medicine, (2022), 28, 10, (2133-2144), 10.1038/s41591-022-02003-x)

KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape

Xingliang Guo

Fingerprint

Collaborations and top research areas from the last five years

Research output

CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ ZAP70 Signaling Axis

Correction to: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape (Nature Medicine, (2022), 28, 10, (2133-2144), 10.1038/s41591-022-02003-x)

KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape